International Max Planck Research School for Translational Psychiatry (IMPRS-TP)
Call for applications - Research in a translational setting
International Max Planck Research School for Translational Psychiatry (IMPRS-TP)
IMPRS-TP’s research aim is the translation of basic and clinical research into practical solutions for improved diagnosis and treatment of people affected by psychiatric disorders such as depression, schizophrenia, mood and anxiety disorders.
Visit employer page
JOB DETAILS
Published: 1 month ago
Application deadline: Jan 02
Location: München, Germany
You need to sign in or create an account to save this job
Please mention that you found this job on Academic Positions when applying.
SHARE THIS JOB

Call for applications - Research in a translational setting

The International Max Planck Research School for Translational Psychiatry (IMPRS-TP) is offering PhD positions in molecular, cellular and systemic psychiatric research. Students are exposed to a wide range of scientific questions and methods covering areas of molecular medicine, neuroscience, psychiatry, quantitative epigenetics and imaging, neuroimaging, design-based stereology and clinical studies.

Research in a translational setting

In addition to the traditional doctorate positions, trainee medical doctors are given the opportunity to be enrolled on an integrated PhD/residence program in psychiatry. Highlighting the translational facet, doctorate students will receive insights into clinical aspects of disease and trainee medical doctors will gain PhD level research expertise, while also developing their clinical skills.

Receive exceptional training for a successful career in research, clinic and academia!

Structured curriculum: Core Course | Lecture Series | Methods Workshops | Soft Skills

Topics addressed range from molecular and cellular neuroscience, behavioral assessments, electrophysiology and brain imaging to psychological and clinical measures and outcomes, as well as, epidemiology, statistics and bioinformatics.

Work in an environment of scientific excellence and interdisciplinary collaboration

IMPRS-TP is a joint initiative of leading scientists from the Max Planck Institute of Psychiatry, the Max Planck Institute of Neurobiology and the Ludwig Maximillians University, Munich. Further collaborations have been established with King’s College London, UK, the Munich Medical Research School (MMRS), Germany, and the Graduate School of Systemic Neurosciences (GSN), Martinsried, Germany. IMPRS-TP is co-funded by the Else-Kröner-Fresenius Foundation.

Call for applications

IMPRS-TP welcomes applications from doctoral candidates coming from any country who hold a 4 year Bachelor or Master of Science (or an equivalent) degree in a relevant field or a Medical Degree. Applications from trainee medical doctors with laboratory experience are particularly encouraged. IMPRS-TP will only accept applications submitted through the IMPRS-TP online application tool: https://imprs-tp.cloud.opencampus.net/. Applications submitted by mail or email will not be considered. Application deadline is January 2nd, 2018.

For more information on the program and how to apply, please visit www.imprs-tp.mpg.de

Continue reading
You need to sign in or create an account to save this job

SUBSCRIBE TO JOBS LIKE THIS

  • Job types

SIMILAR JOBS

Neurosciences in Berlin – International PhD Fellowships
Einstein Center for Neurosciences Berlin (ECN)
Published 11 days ago
12 fully funded Ph.D. positions at Cologne Graduate School Ageing Research
Cologne Graduate School of Ageing Research (CGA)
Published 19 days ago
2 PhD positions in synthetic microbiology
Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute (HKI)
Published 4 days ago
PhD Position: Target Identification
Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute (HKI)
Published 4 days ago
The International Max Planck Research School for Molecular Life Sciences (IMPRS-LS)
International Max Planck Research School for Molecular and Cellular Life Sciences
Published 4 days ago